GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-6.77%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$287M
AUM Growth
+$287M
(-7.6%)
Cap. Flow
-$57.4M
Cap. Flow
% of AUM
-19.96%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
78
New
11
Increased
22
Reduced
19
Closed
17
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$11.8M |
| 2 |
Biohaven
BHVN
|
$7.12M |
| 3 |
Rezolute
RZLT
|
$6.11M |
| 4 |
CG Oncology
CGON
|
$5.84M |
| 5 |
Corbus Pharmaceuticals
CRBP
|
$5.34M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$11.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.11M |
| 3 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$6.65M |
| 4 |
TG Therapeutics
TGTX
|
$5.78M |
| 5 |
Insmed
INSM
|
$5.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
DCPH
77
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-176,513
| Closed | -$2.78M |
|
|
MRNS
78
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-285,000
| Closed | -$2.58M |
|